Search

Your search keyword '"Chen, Yuh-Min"' showing total 1,344 results

Search Constraints

Start Over You searched for: Author "Chen, Yuh-Min" Remove constraint Author: "Chen, Yuh-Min"
1,344 results on '"Chen, Yuh-Min"'

Search Results

1. ReXamine-Global: A Framework for Uncovering Inconsistencies in Radiology Report Generation Metrics

10. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

14. Modifications of lipid pathways restrict SARS-CoV-2 propagation in human induced pluripotent stem cell-derived 3D airway organoids

15. Circulating mitochondrial cell-free DNA dynamics in patients with mycobacterial pulmonary infections: Potential for a novel biomarker of disease

16. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study

21. Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung Cancer

30. Supporting E-Learning with Emotion Regulation for Students with Autism Spectrum Disorder

32. IMpower010: Final disease-free survival (DFS) and second overall survival (OS) interim results after ≥5 years of follow up of a phase III study of adjuvant atezolizumab vs best supportive care in resected stage IB-IIIA non-small cell lung cancer (NSCLC).

34. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

35. Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia

37. Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations

38. Neutrophils Recruited by NKX2‐1 Suppression via Activation of CXCLs/CXCR2 Axis Promote Lung Adenocarcinoma Progression.

40. Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

43. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types

44. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.

50. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

Catalog

Books, media, physical & digital resources